News – Page 787 – Endpoints News

RemeGen readies $514M IPO as HKEX adds jewel to the crown

5 years ago

Arena's Amit Munshi spins out his neuro sub into a biotech startup, with $56M for the baptism

5 years ago

Chinese rare disease player inks first deal around narcolepsy drug Wakix after grabbing $80M to build an ecosystem

5 years ago

Eli Lilly lines up a blockbuster deal for Covid-19 antibody, right after it failed a NIAID trial

5 years ago

Enhertu picks up another win for AstraZeneca and Daiichi Sankyo, joining the priority review lane for gastric cancer

5 years ago

Scientists warn Americans are expecting too much from a coronavirus vaccine

5 years ago

Covid-19 roundup: Boehringer pulls a drug out of the pipeline for a PhII Covid-19 trial; Novavax delays PhIII trial ...

5 years ago

Novartis CEO Vas Narasimhan signs off on a $231M deal to try something new in the R&D fight against SARS-CoV-2

5 years ago

A dark horse entrant into the spinal muscular atrophy field doubles its value on some PhII data

5 years ago

News briefing: Novartis' Zolgensma hits blockbuster status, triggering $80M milestone; Caris raises $310M for genomic ...

5 years ago

Sobi bets $250M cash, about $1B in milestones for rights to a C3 therapy being pushed through 5 pivotal trials

5 years ago

A month after Illumina's big Grail buyout, Exact Sciences scoops up liquid biopsy rival Thrive for a relative bargain

5 years ago

Bayer follows R&D deal spree by raiding Roche's cancer group for its new research chief

5 years ago

Once rejected, Kala's dry eye drug now gains entry to a field where Novartis is grooming its own blockbuster

5 years ago

After falling behind the leaders, dissed by some experts, biotech showman Patrick Soon-Shiong finally gets his ...

5 years ago

Where's the Pfizer efficacy readout? CEO Bourla says 'soon,' but you're going to have to wait for it

5 years ago

The disruptors at EQRx have their eyes on the PD-(L)1 market — teeing up $150M cash to grab 2 backbone therapies ...

5 years ago

Patrick Soon-Shiong steps down as CEO of NantKwest, a linchpin of his 'Cancer Moonshot'

5 years ago

Covid-19 roundup: Medicare and Medicaid recipients could receive vaccines for free — report

5 years ago

Researchers shutter 2 Covid-19 studies as monitors flag Eli Lilly antibodies as a flop for pneumonia, hospitalized ...

5 years ago

Three years into a PhIII program for a failed Duchenne MD drug, Catabasis hauls down the flag and admits defeat

5 years ago

Ultragenyx slams the brakes on rare disease study after all 5 patients are hit with a serious setback

5 years ago

News briefing: AstraZeneca follows Amgen down KRAS/SHP2 combo path; Vallon Pharmaceuticals files for $17 million ...

5 years ago

Crinetics' acromegaly drug hits primary PhII endpoint, but investors can't make up their minds

5 years ago

First page Previous page 784 785 786787788 789 790 Next page Last page